Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder

References

• Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar
• Verheijen, R, Kuijpers, HJH, Schlingemann, RO, et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase. J Cell Sci 1989; 92: 123–130
   PubMed Web of Science ®Google Scholar
• Verheijen, R, Kuijpers, HJH, van Driel, R, et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen II. Localization in mitotic cells and association with chromosomes. J Cell Sci 1989; 92: 531–540
   PubMed Web of Science ®Google Scholar
• Fontana, D, Bellina, M, Gubetta, G, et al. Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol 1992; 148: 1149–1151
   PubMed Web of Science ®Google Scholar
• Limas C, Bigler A, Bair R, Bernhart P, Reddy P. Proliferfation activity of urothelial neoplasms: comparison of BrdU incorporation, Ki-67 expression and nucleolar organiser regions. J Clin Pathol 1993; 46: 159–165
   PubMed Web of Science ®Google Scholar
• Hall PA, Woods A. Immunohistochemical markers of cell proliferation: achievements, problems and prospects. Cell Tissue Kinetics 1990; 23: 531–549
   Google Scholar
• Key, G, Larson Petersen, J, Becker, MHG, et al. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol 1993; 46: 1080–1084
   PubMed Web of Science ®Google Scholar
• Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. International histological classification of tumor No. 10. WHO, Geneva 1973
   Google Scholar
• TNM Classification of Malignant Tumors, MH Harmen. Union Internationale Contre le Cancer, Geneva 1978
   Google Scholar
• Delahunt B, Nacey JN. Renal cell carcinoma: histological indicators of prognosis. Pathology 1987; 19: 258–263
   PubMed Web of Science ®Google Scholar
• Tsujihashi H, Nakanishi A, Matsuda H, Uejima S, Kurita T. Cell proliferation of human bladder tumors determined in BrdU and Ki-67 immunostaining. J Urol 1991; 145: 846–849
   PubMed Web of Science ®Google Scholar
• Bush, C, Price, P, Norton, J, et al. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer 1991; 64: 357–360
   PubMed Web of Science ®Google Scholar
• Mulder, AH, van Hootegem, JC, Slyvester, R, et al. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle related nuclear antigen (Ki-67). J Pathol 1992; 166: 37–43
   PubMed Web of Science ®Google Scholar
• Okamura K, Miyake K, Koshikawa T, Asai J. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 1990; 144: 875–878
   PubMed Web of Science ®Google Scholar
• Stavropoulos, NE, Ioackim-Velogianni, E, Hastazeris, K, et al. Growth fractions in bladder cancer defined by Ki-67: association with cancer grade, category and recurrence rate of superficial lesions. Brit J Urol 1993; 72: 736–739
   PubMedGoogle Scholar
• McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1. Histopathology 1993; 22: 355–360
   PubMed Web of Science ®Google Scholar
• Pich A, Chiusa L, Comino A, Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinoma. Virchow Arch 1994; 424: 143–148
   PubMed Web of Science ®Google Scholar
• Mazerolles, C, Rishmann, P, Chopin, D, et al. Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparisons with Ki-67 antibody. Histopathology 1994; 25: 563–568
   PubMed Web of Science ®Google Scholar
• Hake, R, Vorreuther, R, Borchmann, P, et al. Monoklonale Antikorper (MIB 1, PC10, 486p & p53) als prognostische Parameter beim rezidivierenden urothelialen Karzinom der Harnblase. Ver Deutsch Gesell Pathol 1993; 77: 236–240
   PubMedGoogle Scholar
• Hall PA. Assessment of cell proliferation markers with particular emphasis on Ki-67 and PCNA. Dako monograph. 1993
   Google Scholar
• Delahunt B, Bethwaite PB, Thornton A, Ribas JL. Proliferation kinetics of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome. Cancer 1995; 75: 2714–2719
   PubMed Web of Science ®Google Scholar
• Wagner, U, Sauter, G, Moch, H, et al. Patterns of p53, erb-2 and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 1995; 26: 970–978
   PubMed Web of Science ®Google Scholar